Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0WI9M
|
|||
| Drug Name |
Imidazolidine derivative 1
|
|||
| Synonyms |
PMID27724045-Compound-1
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
GSK
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H15ClF3N5O2
|
|||
| Canonical SMILES |
CN1C(CN(C1=O)C2=NC=CC=N2)C(=O)NCC3=C(C(=CC=C3)C(F)(F)F)Cl
|
|||
| InChI |
1S/C17H15ClF3N5O2/c1-25-12(9-26(16(25)28)15-22-6-3-7-23-15)14(27)24-8-10-4-2-5-11(13(10)18)17(19,20)21/h2-7,12H,8-9H2,1H3,(H,24,27)
|
|||
| InChIKey |
VEJSCJTUSBXATQ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | P2X purinoceptor 7 (P2RX7) | Target Info | Antagonist | [1] |
| Target's Patent Info | P2X purinoceptor 7 (P2RX7) | Target's Patent Info | [1] | |
| KEGG Pathway | Calcium signaling pathway | |||
| Neuroactive ligand-receptor interaction | ||||
| Reactome | The NLRP3 inflammasome | |||
| WikiPathways | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | P2X7 receptor antagonists: a patent review (2010-2015).Expert Opin Ther Pat. 2017 Mar;27(3):257-267. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.